FDA Ends Olmesartan Safety Review, But...
The FDA announced on Tuesday that it had completed its safety review of the antihypertensive drug olmesartan (sold as Benicar and other names). The investigation was initiated in 2010 when results from the ROADMAP trial showed that patients with type 2 diabetes taking olmesartan had an increased risk of cardiovascular death. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 25, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
Affordrx.com Now Makes Benicar and Other Hypertension Prescriptions...
AffordRx provides savings on beta blockers and thousands of medications.(PRWeb May 31, 2014)Read the full story at http://www.prweb.com/releases/2014/05/prweb11885958.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 1, 2014 Category: Pharmaceuticals Source Type: news
Levin, Papantonio Law Firm Files Benicar Lawsuit
The Levin, Papantonio law firm has filed a Benicar lawsuit on behalf of a Texas man who suffered sprue-like enteropathy while using the blood pressure medication Benicar.(PRWeb March 18, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11659164.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2014 Category: Pharmaceuticals Source Type: news
MedicationDiscountCard.com Helps Combat the Silent Killer with Benicar...
Benicar prescription discount cards help save patients 10-75% on high blood pressure medication.(PRWeb January 22, 2014)Read the full story at http://www.prweb.com/releases/Benicar/Coupon/prweb11507601.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 22, 2014 Category: Pharmaceuticals Source Type: news
Drug Injury Attorney Jeffrey D. DeCarlo Comments on FDA Warning About...
The attorney at the Law Offices of Jeffrey D. DeCarlo discusses steps patients who have been harmed by pharmaceutical products can take to protect their rights.(PRWeb December 19, 2013)Read the full story at http://www.prweb.com/releases/benicar-health-problems/lawyer-fl/prweb11408865.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 20, 2013 Category: Pharmaceuticals Source Type: news
Flood Law Group to Sponsor BenicarLawsuits.org
The personal injury lawyers at Flood Law Group announce the release of the new website, BenicarLawsuits.org, an online resource dedicated to educating consumers about the risks associated with the...(PRWeb July 26, 2013)Read the full story at http://www.prweb.com/releases/benicar-lawsuits/website/prweb10966557.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 27, 2013 Category: Pharmaceuticals Source Type: news
FDA Adds GI Warning to Benicar Label
WASHINGTON (MedPage Today) -- The FDA ordered the maker of the blood pressure drug olmesartan (Benicar) to add a warning about risk of the intestinal condition known as sprue-like enteropathy to the drug's label. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 3, 2013 Category: Cardiology Source Type: news
FDA warns on Daiichi Sankyo blood pressure drugs
(Reuters) - U.S. health regulators warned on Wednesday that Daiichi Sankyo Inc's blood pressure drugs Benicar, Benicar HCT, Azor and Tribenzor can cause severe, chronic diarrhea and substantial weight loss, sometimes requiring hospitalization. (Source: Reuters: Health)
Source: Reuters: Health - July 3, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
Enteropathy may develop months to years after starting olmesartan, and sometimes requires hospitalization. (Source: FDA MedWatch)
Source: FDA MedWatch - July 3, 2013 Category: American Health Source Type: news
